{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T20:49:07Z","timestamp":1773866947525,"version":"3.50.1"},"reference-count":90,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T00:00:00Z","timestamp":1628726400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005416","name":"Norges Forskningsr\u00e5d","doi-asserted-by":"publisher","award":["309871\/E50"],"award-info":[{"award-number":["309871\/E50"]}],"id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005416","name":"Norges Forskningsr\u00e5d","doi-asserted-by":"publisher","award":["309871\/E50"],"award-info":[{"award-number":["309871\/E50"]}],"id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"abstract":"<jats:p>Mutations are known to cause perturbations in essential functional features of integral membrane proteins, including ion channels. Even restricted or point mutations can result in substantially changed properties of ion currents. The additive effect of these alterations for a specific ion channel can result in significantly changed properties of the action potential (AP). Both AP shortening and AP prolongation can result from known mutations, and the consequences can be life-threatening. Here, we present a computational method for identifying new drugs utilizing combinations of existing drugs. Based on the knowledge of theoretical effects of existing drugs on individual ion currents, our aim is to compute optimal combinations that can \u2018repair\u2019 the mutant AP waveforms so that the baseline AP-properties are restored. More specifically, we compute optimal, combined, drug concentrations such that the waveforms of the transmembrane potential and the cytosolic calcium concentration of the mutant cardiomyocytes (CMs) becomes as similar as possible to their wild type counterparts after the drug has been applied. In order to demonstrate the utility of this method, we address the question of computing an optimal drug for the short QT syndrome type 1 (SQT1). For the SQT1 mutation N588K, there are available data sets that describe the effect of various drugs on the mutated K<jats:sup>+<\/jats:sup>channel. These published findings are the basis for our computational analysis which can identify optimal compounds in the sense that the AP of the mutant CMs resembles essential biomarkers of the wild type CMs. Using recently developed insights regarding electrophysiological properties among myocytes from different species, we compute optimal drug combinations for hiPSC-CMs, rabbit ventricular CMs and adult human ventricular CMs with the SQT1 mutation. Since the \u2018composition\u2019 of ion channels that form the AP is different for the three types of myocytes under consideration, so is the composition of the optimal drug.<\/jats:p>","DOI":"10.1371\/journal.pcbi.1009233","type":"journal-article","created":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T19:08:28Z","timestamp":1628795308000},"page":"e1009233","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":15,"title":["A computational method for identifying an optimal combination of existing drugs to repair the action potentials of SQT1 ventricular myocytes"],"prefix":"10.1371","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4234-9094","authenticated-orcid":true,"given":"Karoline Horgmo","family":"J\u00e6ger","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7421-5977","authenticated-orcid":true,"given":"Andrew G.","family":"Edwards","sequence":"additional","affiliation":[]},{"given":"Wayne R.","family":"Giles","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2362-146X","authenticated-orcid":true,"given":"Aslak","family":"Tveito","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2021,8,12]]},"reference":[{"issue":"6","key":"pcbi.1009233.ref001","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/CRD.0b013e3181c07592","article-title":"Short QT syndrome: a review","volume":"17","author":"U Patel","year":"2009","journal-title":"Cardiology in Review"},{"issue":"4","key":"pcbi.1009233.ref002","first-page":"e1482","article-title":"Calibration of ionic and cellular cardiac electrophysiology models","volume":"12","author":"DG Whittaker","year":"2020","journal-title":"Wiley Interdisciplinary Reviews: Systems Biology and Medicine"},{"issue":"1","key":"pcbi.1009233.ref003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gene.2012.12.061","article-title":"Cardiac channelopathies: genetic and molecular mechanisms","volume":"517","author":"H Abriel","year":"2013","journal-title":"Gene"},{"issue":"1","key":"pcbi.1009233.ref004","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3390\/biology6010007","article-title":"Cardiac channelopathies and sudden death: recent clinical and genetic advances","volume":"6","author":"A Fern\u00e1ndez-Falgueras","year":"2017","journal-title":"Biology"},{"issue":"2","key":"pcbi.1009233.ref005","article-title":"Nonlinear and stochastic dynamics in the heart","volume":"543","author":"Z Qu","year":"2014","journal-title":"Physics Reports"},{"issue":"1","key":"pcbi.1009233.ref006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41572-020-0188-7","article-title":"Inherited cardiac arrhythmias","volume":"6","author":"PJ Schwartz","year":"2020","journal-title":"Nature Reviews Disease Primers"},{"issue":"8","key":"pcbi.1009233.ref007","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1161\/01.CIR.0000085071.28695.C4","article-title":"Short QT syndrome: a familial cause of sudden death","volume":"108","author":"F Gaita","year":"2003","journal-title":"Circulation"},{"issue":"2","key":"pcbi.1009233.ref008","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000047299","article-title":"Idiopathic short QT interval: a new clinical syndrome?","volume":"94","author":"I Gussak","year":"2000","journal-title":"Cardiology"},{"issue":"4","key":"pcbi.1009233.ref009","first-page":"401","article-title":"Short QT syndrome: from bench to bedside","volume":"3","author":"C Patel","year":"2010","journal-title":"Circulation: Arrhythmia and Electrophysiology"},{"key":"pcbi.1009233.ref010","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3389\/fcvm.2018.00149","article-title":"Recent advances in short QT syndrome","volume":"5","author":"O Campuzano","year":"2018","journal-title":"Frontiers in Cardiovascular Medicine"},{"issue":"11","key":"pcbi.1009233.ref011","doi-asserted-by":"crossref","DOI":"10.1016\/j.hrthm.2017.07.026","article-title":"Phenotypic variability in LQT3 human induced pluripotent stem cell-derived cardiomyocytes and their response to anti-arrhythmic pharmacological therapy: an in silico approach","volume":"14","author":"M Paci","year":"2017","journal-title":"Heart Rhythm"},{"issue":"2","key":"pcbi.1009233.ref012","doi-asserted-by":"crossref","first-page":"e1008089","DOI":"10.1371\/journal.pcbi.1008089","article-title":"Computational prediction of drug response in short QT syndrome type 1 based on measurements of compound effect in stem cell-derived cardiomyocytes","volume":"17","author":"KH J\u00e6ger","year":"2021","journal-title":"PLoS Computational Biology"},{"issue":"8","key":"pcbi.1009233.ref013","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/j.jacc.2004.02.034","article-title":"Short QT syndrome: pharmacological treatment","volume":"43","author":"F Gaita","year":"2004","journal-title":"Journal of the American College of Cardiology"},{"issue":"2","key":"pcbi.1009233.ref014","doi-asserted-by":"crossref","first-page":"76","DOI":"10.15420\/aer.2014.3.2.76","article-title":"Short QT syndrome\u2013review of diagnosis and treatment","volume":"3","author":"B Rudic","year":"2014","journal-title":"Arrhythmia & Electrophysiology Review"},{"issue":"13","key":"pcbi.1009233.ref015","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.jacc.2013.09.078","article-title":"Novel insight into the natural history of short QT syndrome","volume":"63","author":"A Mazzanti","year":"2014","journal-title":"Journal of the American College of Cardiology"},{"issue":"6","key":"pcbi.1009233.ref016","first-page":"1460","article-title":"Short QT interval prevalence and clinical outcomes in a pediatric population","volume":"8","author":"K Guerrier","year":"2015","journal-title":"Circulation: Arrhythmia and Electrophysiology"},{"issue":"5","key":"pcbi.1009233.ref017","doi-asserted-by":"crossref","first-page":"e1002061","DOI":"10.1371\/journal.pcbi.1002061","article-title":"Simulation of the undiseased human cardiac ventricular action potential: Model formulation and experimental validation","volume":"7","author":"T O\u2019Hara","year":"2011","journal-title":"PLoS Computational Biology"},{"issue":"17","key":"pcbi.1009233.ref018","doi-asserted-by":"crossref","first-page":"4533","DOI":"10.1113\/JP277724","article-title":"A computational model of induced pluripotent stem-cell derived cardiomyocytes incorporating experimental variability from multiple data sources","volume":"597","author":"D Kernik","year":"2019","journal-title":"The Journal of Physiology"},{"issue":"1","key":"pcbi.1009233.ref019","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.yjmcc.2009.09.019","article-title":"A novel computational model of the human ventricular action potential and Ca transient","volume":"48","author":"E Grandi","year":"2010","journal-title":"Journal of Molecular and Cellular Cardiology"},{"issue":"01","key":"pcbi.1009233.ref020","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1017\/S0033583506004227","article-title":"Computational biology in the study of cardiac ion channels and cell electrophysiology","volume":"39","author":"Y Rudy","year":"2006","journal-title":"Quarterly Reviews of Biophysics"},{"key":"pcbi.1009233.ref021","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/23034","article-title":"Linking a genetic defect to its cellular phenotype in a cardiac arrhythmia","volume":"400","author":"CE Clancy","year":"1999","journal-title":"Nature"},{"issue":"10","key":"pcbi.1009233.ref022","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1161\/hc1002.105183","article-title":"Na+ Channel Mutation That Causes Both Brugada and Long-QT Syndrome Phenotypes: A Simulation Study of Mechanism","volume":"105","author":"CE Clancy","year":"2002","journal-title":"Circulation"},{"issue":"6","key":"pcbi.1009233.ref023","doi-asserted-by":"crossref","first-page":"H3480","DOI":"10.1152\/ajpheart.00476.2007","article-title":"L-type Ca2+ channel mutations and T-wave alternans: a model study","volume":"293","author":"ZI Zhu","year":"2007","journal-title":"American Journal of Physiology-Heart and Circulatory Physiology"},{"issue":"1","key":"pcbi.1009233.ref024","doi-asserted-by":"crossref","first-page":"H66","DOI":"10.1152\/ajpheart.00312.2006","article-title":"Pharmacogenetics and anti-arrhythmic drug therapy: a theoretical investigation","volume":"292","author":"CE Clancy","year":"2007","journal-title":"American Journal of Physiology-Heart and Circulatory Physiology"},{"issue":"2","key":"pcbi.1009233.ref025","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.mbs.2008.12.001","article-title":"A note on a method for determining advantageous properties of an anti-arrhythmic drug based on a mathematical model of cardiac cells","volume":"217","author":"A Tveito","year":"2009","journal-title":"Mathematical Biosciences"},{"issue":"1","key":"pcbi.1009233.ref026","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/cvr\/cvr044","article-title":"Simulation of multiple ion channel block provides improved early prediction of compounds\u2019 clinical torsadogenic risk","volume":"91","author":"GR Mirams","year":"2011","journal-title":"Cardiovascular Research"},{"key":"pcbi.1009233.ref027","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-30030-6","volume-title":"Computing Characterizations of Drugs for Ion Channels and Receptors Using Markov Models","author":"A Tveito","year":"2016"},{"issue":"7","key":"pcbi.1009233.ref028","doi-asserted-by":"crossref","first-page":"e007394","DOI":"10.1161\/JAHA.117.007394","article-title":"Modeling Short QT Syndrome Using Human-Induced Pluripotent Stem Cell\u2013Derived Cardiomyocytes","volume":"7","author":"I El-Battrawy","year":"2018","journal-title":"Journal of the American Heart Association"},{"issue":"3","key":"pcbi.1009233.ref029","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/cpt.1449","article-title":"Drug Testing in Human-Induced Pluripotent Stem Cell\u2013Derived Cardiomyocytes From a Patient With Short QT Syndrome Type 1","volume":"106","author":"Z Zhao","year":"2019","journal-title":"Clinical Pharmacology & Therapeutics"},{"issue":"6","key":"pcbi.1009233.ref030","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/bjp.2008.325","article-title":"Pharmacology of the short QT syndrome N588K-hERG K+ channel mutation: differential impact on selected class I and class III antiarrhythmic drugs","volume":"155","author":"M McPate","year":"2008","journal-title":"British Journal of Pharmacology"},{"issue":"1","key":"pcbi.1009233.ref031","doi-asserted-by":"crossref","first-page":"17626","DOI":"10.1038\/s41598-018-35858-7","article-title":"Inversion and computational maturation of drug response using human stem cell derived cardiomyocytes in microphysiological systems","volume":"8","author":"A Tveito","year":"2018","journal-title":"Scientific Reports"},{"key":"pcbi.1009233.ref032","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.3389\/fphar.2019.01648","article-title":"Improved computational identification of drug response using optical measurements of human stem cell derived cardiomyocytes in microphysiological systems","volume":"10","author":"KH J\u00e6ger","year":"2020","journal-title":"Frontiers in Pharmacology"},{"issue":"1","key":"pcbi.1009233.ref033","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-66910-0","article-title":"Computational translation of drug effects from animal experiments to human ventricular myocytes","volume":"10","author":"A Tveito","year":"2020","journal-title":"Scientific Reports"},{"issue":"2","key":"pcbi.1009233.ref034","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.bbrc.2005.06.112","article-title":"The N588K-HERG K+ channel mutation in the\u2019short QT syndrome\u2019: mechanism of gain-in-function determined at37 \u00b0C","volume":"334","author":"MJ McPate","year":"2005","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"1","key":"pcbi.1009233.ref035","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1046\/j.1540-8167.2005.04470.x","article-title":"Further insights into the effect of quinidine in short QT syndrome caused by a mutation in HERG","volume":"16","author":"C Wolpert","year":"2005","journal-title":"Journal of Cardiovascular Electrophysiology"},{"issue":"5","key":"pcbi.1009233.ref036","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.1529\/biophysj.104.047449","article-title":"A mathematical treatment of integrated Ca dynamics within the ventricular myocyte","volume":"87","author":"TR Shannon","year":"2004","journal-title":"Biophysical Journal"},{"issue":"10","key":"pcbi.1009233.ref037","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1093\/eurheartj\/ehy761","article-title":"Transgenic short-QT syndrome 1 rabbits mimic the human disease phenotype with QT\/action potential duration shortening in the atria and ventricles and increased ventricular tachycardia\/ventricular fibrillation inducibility","volume":"40","author":"KE Odening","year":"2019","journal-title":"European Heart Journal"},{"key":"pcbi.1009233.ref038","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3389\/fphy.2017.00048","article-title":"A cell-based framework for numerical modeling of electrical conduction in cardiac tissue","volume":"5","author":"A Tveito","year":"2017","journal-title":"Frontiers in Physics"},{"issue":"5","key":"pcbi.1009233.ref039","doi-asserted-by":"crossref","first-page":"e1007042","DOI":"10.1371\/journal.pcbi.1007042","article-title":"Properties of cardiac conduction in a cell-based computational model","volume":"15","author":"KH J\u00e6ger","year":"2019","journal-title":"PLoS Computational Biology"},{"key":"pcbi.1009233.ref040","first-page":"1","volume-title":"Modeling Excitable Tissue","author":"KH J\u00e6ger","year":"2020"},{"key":"pcbi.1009233.ref041","article-title":"MFEM: A Modular Finite Element Library","author":"R Anderson","year":"2020","journal-title":"Computers & Mathematics with Applications"},{"key":"pcbi.1009233.ref042","unstructured":"MFEM: Modular Finite Element Methods [Software]; 2021. mfem.org."},{"key":"pcbi.1009233.ref043","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3389\/fphy.2020.579461","article-title":"Efficient numerical solution of the EMI model representing the extracellular space (E), cell membrane (M) and intracellular space (I) of a collection of cardiac cells","volume":"8","author":"KH J\u00e6ger","year":"2021","journal-title":"Frontiers in Physics"},{"key":"pcbi.1009233.ref044","first-page":"44","volume-title":"Modeling Excitable Tissue","author":"KH J\u00e6ger","year":"2020"},{"key":"pcbi.1009233.ref045","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1038\/srep02100","article-title":"MICE models: superior to the HERG model in predicting Torsade de Pointes","volume":"3","author":"J Kramer","year":"2013","journal-title":"Scientific Reports"},{"key":"pcbi.1009233.ref046","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.vascn.2016.03.009","article-title":"An evaluation of 30 clinical drugs against the comprehensive in vitro proarrhythmia assay (CiPA) proposed ion channel panel","volume":"81","author":"W Crumb","year":"2016","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"pcbi.1009233.ref047","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0022-2828(87)80005-6","article-title":"Calcium-agonists","volume":"19","author":"M Bechem","year":"1987","journal-title":"Journal of Molecular and Cellular Cardiology"},{"issue":"1","key":"pcbi.1009233.ref048","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1161\/01.RES.56.1.87","article-title":"A dihydropyridine (Bay k 8644) that enhances calcium currents in guinea pig and calf myocardial cells. A new type of positive inotropic agent","volume":"56","author":"G Thomas","year":"1985","journal-title":"Circulation Research"},{"key":"pcbi.1009233.ref049","doi-asserted-by":"crossref","first-page":"766","DOI":"10.3389\/fphys.2017.00766","article-title":"An automated platform for assessment of congenital and drug-induced arrhythmia with hiPSC-derived cardiomyocytes","volume":"8","author":"WL McKeithan","year":"2017","journal-title":"Frontiers in Physiology"},{"key":"pcbi.1009233.ref050","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3389\/fphys.2013.00166","article-title":"In silico investigation of the short QT syndrome, using human ventricle models incorporating electromechanical coupling","volume":"4","author":"I Adeniran","year":"2013","journal-title":"Frontiers in Physiology"},{"key":"pcbi.1009233.ref051","doi-asserted-by":"crossref","unstructured":"Whittaker DG, Colman MA, Ni H, Hancox JC, Zhang H. In silico investigation of short QT syndrome-linked potassium channel mutations on electro-mechanical function of human atrial cells. In: 2015 Computing in Cardiology Conference (CinC). IEEE; 2015. p. 853\u2013856.","DOI":"10.1109\/CIC.2015.7411045"},{"issue":"10","key":"pcbi.1009233.ref052","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1016\/j.hrthm.2015.05.024","article-title":"New echocardiographic insights in short QT syndrome: more than a channelopathy?","volume":"12","author":"S Frea","year":"2015","journal-title":"Heart Rhythm"},{"issue":"9","key":"pcbi.1009233.ref053","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.1016\/j.hrthm.2015.06.036","article-title":"Reply to the Editor\u2014Altered in vivo systolic function in the short QT syndrome anticipated in silico","volume":"12","author":"S Frea","year":"2015","journal-title":"Heart Rhythm"},{"issue":"7","key":"pcbi.1009233.ref054","doi-asserted-by":"crossref","first-page":"757","DOI":"10.2165\/00003495-200969070-00001","article-title":"Novel approaches for pharmacological management of atrial fibrillation","volume":"69","author":"JR Ehrlich","year":"2009","journal-title":"Drugs"},{"key":"pcbi.1009233.ref055","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jhealeco.2016.01.012","article-title":"Innovation in the pharmaceutical industry: New estimates of R&D costs","volume":"47","author":"J DiMasi","year":"2016","journal-title":"Journal of Health Economics"},{"issue":"3","key":"pcbi.1009233.ref056","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrd3078","article-title":"How to improve R&D productivity: the pharmaceutical industry\u2019s grand challenge","volume":"9","author":"S Paul","year":"2010","journal-title":"Nature Reviews Drug Discovery"},{"issue":"6","key":"pcbi.1009233.ref057","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1113\/jphysiol.2014.279554","article-title":"A computational modelling approach combined with cellular electrophysiology data provides insights into the therapeutic benefit of targeting the late Na+ current","volume":"593","author":"PC Yang","year":"2015","journal-title":"The Journal of Physiology"},{"key":"pcbi.1009233.ref058","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.yjmcc.2016.08.011","article-title":"A computational model predicts adjunctive pharmacotherapy for cardiac safety via selective inhibition of the late cardiac Na current","volume":"99","author":"PC Yang","year":"2016","journal-title":"Journal of Molecular and Cellular Cardiology"},{"issue":"3","key":"pcbi.1009233.ref059","first-page":"409","article-title":"Inotropic effects of electric currents. I. Positive and negative effects of constant electric currents or current pulses applied during cardiac action potentials. II. Hypotheses: calcium movements, excitation-contraction coupling and inotropic effects","volume":"24","author":"EH Wood","year":"1969","journal-title":"Circulation Research"},{"issue":"21","key":"pcbi.1009233.ref060","doi-asserted-by":"crossref","first-page":"6599","DOI":"10.1113\/JP273651","article-title":"Cardiac action potential repolarization revisited: early repolarization shows all-or-none behaviour","volume":"595","author":"B Trenor","year":"2017","journal-title":"The Journal of Physiology"},{"issue":"16","key":"pcbi.1009233.ref061","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1161\/CIRCULATIONAHA.110.000661","article-title":"Late sodium current contributes to the reverse rate-dependent effect of IKr inhibition on ventricular repolarization","volume":"123","author":"L Wu","year":"2011","journal-title":"Circulation"},{"issue":"5","key":"pcbi.1009233.ref062","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1161\/01.RES.76.5.790","article-title":"Effects of action potential duration on excitation-contraction coupling in rat ventricular myocytes: action potential voltage-clamp measurements","volume":"76","author":"R Bouchard","year":"1995","journal-title":"Circulation Research"},{"issue":"2","key":"pcbi.1009233.ref063","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1161\/hh0202.103315","article-title":"Modulation of Ca2+ release in cardiac myocytes by changes in repolarization rate: role of phase-1 action potential repolarization in excitation-contraction coupling","volume":"90","author":"R Sah","year":"2002","journal-title":"Circulation research"},{"issue":"2","key":"pcbi.1009233.ref064","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/toxsci\/kfy299","article-title":"Evaluation of Possible Proarrhythmic Potency: Comparison of the Effect of Dofetilide, Cisapride, Sotalol, Terfenadine, and Verapamil on hERG and Native IKr Currents and on Cardiac Action Potential","volume":"168","author":"P Orvos","year":"2019","journal-title":"Toxicological Sciences"},{"issue":"1","key":"pcbi.1009233.ref065","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1093\/toxsci\/kfv128","article-title":"Proarrhythmia risk assessment in human induced pluripotent stem cell-derived cardiomyocytes using the maestro MEA platform","volume":"147","author":"Y Qu","year":"2015","journal-title":"Toxicological Sciences"},{"key":"pcbi.1009233.ref066","article-title":"The inter-cell-line reproducibility of hERG assay using the whole-cell patch-clamping","volume":"97","author":"Y Katayama","year":"2005","journal-title":"Journal of Pharmacological Sciences"},{"issue":"5","key":"pcbi.1009233.ref067","doi-asserted-by":"crossref","first-page":"H2006","DOI":"10.1152\/ajpheart.00694.2011","article-title":"High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action potentials and ionic currents","volume":"301","author":"J Ma","year":"2011","journal-title":"American Journal of Physiology-Heart and Circulatory Physiology"},{"issue":"3","key":"pcbi.1009233.ref068","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.vascn.2014.09.005","article-title":"Human stem cell-derived cardiomyocytes detect drug-mediated changes in action potentials and ion currents","volume":"70","author":"J Gibson","year":"2014","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"pcbi.1009233.ref069","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-27598-7","volume-title":"Modeling in biopharmaceutics, pharmacokinetics and pharmacodynamics: homogeneous and heterogeneous approaches","author":"P Macheras","year":"2016"},{"issue":"1","key":"pcbi.1009233.ref070","doi-asserted-by":"crossref","first-page":"H66","DOI":"10.1152\/ajpheart.00312.2006","article-title":"Pharmacogenetics and anti-arrhythmic drug therapy: A theoretical investigation","volume":"292","author":"C Clancy","year":"2007","journal-title":"American Journal of Physiology-Heart and Circulatory Physiology"},{"issue":"1","key":"pcbi.1009233.ref071","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1515\/cmb-2018-0004","article-title":"Computing optimal properties of drugs using mathematical models of single channel dynamics","volume":"6","author":"A Tveito","year":"2018","journal-title":"Computational and Mathematical Biophysics"},{"key":"pcbi.1009233.ref072","first-page":"3","article-title":"Computational models for predictive cardiac ion channel pharmacology","volume":"14","author":"V Yarov-Yarovoy","year":"2014","journal-title":"Drug Discovery Today: Disease Models"},{"key":"pcbi.1009233.ref073","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S0006-3495(96)79568-1","article-title":"Estimating Single-Channel Kinetic Parameters from Idealized Patch-Clamp Data Containing Missed Events","volume":"70","author":"F Qin","year":"1996","journal-title":"Biophysical Journal"},{"key":"pcbi.1009233.ref074","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0006-3495(00)76441-1","article-title":"A Direct Optimization Approach to Hidden Markov Modeling for Single Channel Kinetics","volume":"79","author":"F Qin","year":"2000","journal-title":"Biophysical Journal"},{"issue":"8","key":"pcbi.1009233.ref075","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1016\/j.bpj.2011.02.059","article-title":"MCMC Estimation of Markov Models for Ion Channels","volume":"100","author":"I Siekmann","year":"2011","journal-title":"Biophysical Journal"},{"key":"pcbi.1009233.ref076","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.mbs.2016.04.011","article-title":"Computing rates of Markov models of voltage-gated ion channels by inverting partial differential equations governing the probability density functions of the conducting and non-conducting states","volume":"277","author":"A Tveito","year":"2016","journal-title":"Mathematical Biosciences"},{"issue":"1","key":"pcbi.1009233.ref077","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejps.2008.09.013","article-title":"Multiscale modelling of drug-induced effects on cardiac electrophysiological activity","volume":"36","author":"T Brennan","year":"2009","journal-title":"European Journal of Pharmaceutical Sciences"},{"issue":"7","key":"pcbi.1009233.ref078","doi-asserted-by":"crossref","first-page":"H1466","DOI":"10.1152\/ajpheart.00808.2011","article-title":"An in silico canine cardiac midmyocardial action potential duration model as a tool for early drug safety assessment","volume":"302","author":"MR Davies","year":"2012","journal-title":"American Journal of Physiology-Heart and Circulatory Physiology"},{"issue":"3","key":"pcbi.1009233.ref079","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1111\/j.1476-5381.2012.02200.x","article-title":"Computational assessment of drug-induced effects on the electrocardiogram: from ion channel to body surface potentials","volume":"168","author":"N Zemzemi","year":"2013","journal-title":"British Journal of Pharmacology"},{"issue":"9","key":"pcbi.1009233.ref080","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1016\/j.bpj.2010.08.062","article-title":"Modeling the effect of Kv1. 5 block on the canine action potential","volume":"99","author":"J Almquist","year":"2010","journal-title":"Biophysical Journal"},{"key":"pcbi.1009233.ref081","doi-asserted-by":"crossref","unstructured":"Wang G, Tian X, Lu CJ, Flores H, Maj P, Zhang K, et al. Mechanistic insights into ventricular arrhythmogenesis of hydroxychloroquine and azithromycin for the treatment of COVID-19. bioRxiv. 2020. https:\/\/doi.org\/10.1101\/2020.05.21.108605","DOI":"10.1101\/2020.05.21.108605"},{"issue":"5","key":"pcbi.1009233.ref082","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1124\/mol.118.115220","article-title":"Protocol-Dependent Differences in IC50 Values Measured in Human Ether-\u00c1-Go-Go--Related Gene Assays Occur in a Predictable Way and Can Be Used to Quantify State Preference of Drug Binding","volume":"95","author":"W Lee","year":"2019","journal-title":"Molecular Pharmacology"},{"issue":"3","key":"pcbi.1009233.ref083","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1021\/acs.jcim.9b01085","article-title":"When Does the IC50 Accurately Assess the Blocking Potency of a Drug?","volume":"60","author":"J Gomis-Tena","year":"2020","journal-title":"Journal of Chemical Information and Modeling"},{"issue":"1","key":"pcbi.1009233.ref084","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41540-018-0047-2","article-title":"Population-based mechanistic modeling allows for quantitative predictions of drug responses across cell types","volume":"4","author":"J Gong","year":"2018","journal-title":"NPJ Systems Biology and Applications"},{"issue":"2","key":"pcbi.1009233.ref085","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1113\/jphysiol.2006.126714","article-title":"Regional and tissue specific transcript signatures of ion channel genes in the non-diseased human heart","volume":"582","author":"N Gaborit","year":"2007","journal-title":"The Journal of physiology"},{"issue":"23","key":"pcbi.1009233.ref086","doi-asserted-by":"crossref","first-page":"E2098","DOI":"10.1073\/pnas.1304382110","article-title":"Experimentally calibrated population of models predicts and explains intersubject variability in cardiac cellular electrophysiology","volume":"110","author":"OJ Britton","year":"2013","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"11","key":"pcbi.1009233.ref087","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1113\/jphysiol.2011.223313","article-title":"Exploiting mathematical models to illuminate electrophysiological variability between individuals","volume":"590","author":"AX Sarkar","year":"2012","journal-title":"The Journal of physiology"},{"issue":"5","key":"pcbi.1009233.ref088","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0735-1097(87)80360-1","article-title":"Mexiletine-quinidine combination: electrophysiologic correlates of a favorable antiarrhythmic interaction in humans","volume":"10","author":"HJ Duff","year":"1987","journal-title":"Journal of the American College of Cardiology"},{"issue":"3","key":"pcbi.1009233.ref089","first-page":"1056","article-title":"Interaction between selected sodium and potassium channel blockers in guinea pig papillary muscle","volume":"264","author":"L Wang","year":"1993","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"2","key":"pcbi.1009233.ref090","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1023\/A:1009967429873","article-title":"Antiarrhythmic drug combination therapy","volume":"2","author":"HJ Duff","year":"1998","journal-title":"Cardiac Electrophysiology Review"}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1009233","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,7]],"date-time":"2023-01-07T07:06:03Z","timestamp":1673075163000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1009233"}},"subtitle":[],"editor":[{"given":"Daniel A.","family":"Beard","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2021,8,12]]},"references-count":90,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,8,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1009233","relation":{},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,12]]}}}